Shield Therapeutics plc
STX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £11 | £6 | £6 | £11 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £24 | £20 | £12 | £9 |
| Inventory | £7 | £5 | £3 | £3 |
| Other Curr. Assets | £0 | £0 | £0 | £2 |
| Total Curr. Assets | £41 | £30 | £22 | £25 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £1 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £20 | £15 | £14 | £17 |
| Long-Term Investments | £1 | £1 | £1 | £0 |
| Tax Assets | £0 | £0 | -£14 | £0 |
| Other NC Assets | £0 | £0 | £14 | -£4 |
| Total NC Assets | £21 | £16 | £15 | £14 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £62 | £46 | £37 | £38 |
| Liabilities | – | – | – | – |
| Payables | £16 | £19 | £0 | £4 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £34 | £7 | £21 | £6 |
| Total Curr. Liab. | £50 | £26 | £21 | £11 |
| LT Debt | £27 | £21 | £16 | £16 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | -£0 |
| Total NC Liab. | £27 | £21 | £16 | £16 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £77 | £47 | £37 | £26 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £20 | £16 | £12 | £12 |
| Retained Earnings | -£269 | -£173 | -£162 | -£149 |
| AOCI | -£9 | -£6 | -£6 | -£7 |
| Other Equity | £234 | £162 | £157 | £156 |
| Total Equity | -£15 | -£1 | £0 | £12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £62 | £46 | £37 | £38 |
| Net Debt | £16 | £15 | £9 | £5 |